Ar-Ex Chemicon Profile
Key Indicators
- Authorised Capital ₹ 0.25 M
- Paid Up Capital ₹ 0.25 M
- Company Age 50 Year, 10 Months
- Last Filing with ROC 31 Mar 2017
- Satisfied Charges ₹ 3.65 M
- Revenue Growth -28.00%
- Profit Growth 83.43%
- Ebitda 83.62%
- Net Worth -2.16%
- Total Assets -1.97%
About Ar-Ex Chemicon
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100MH1974PTC017328
-
Company No.
017328
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Mar 1974
-
Date of AGM
29 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ar-Ex Chemicon?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Gunjikar
|
Managing Director | 13-Jun-1995 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ajit Gunjikar
|
Director | 27-Aug-1982 | Current |
|
Sudha Gunjikar
|
Director | 27-Aug-1982 | Current |
Financial Performance of Ar-Ex Chemicon.
Ar-Ex Chemicon Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 28% decrease. The company also saw a substantial improvement in profitability, with a 83.43% increase in profit. The company's net worth dipped by a decrease of 2.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ar-Ex Chemicon?
In 2017, Ar-Ex Chemicon had a promoter holding of 99.20% and a public holding of 0.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ar-Ex Laboratories Private LimitedSatish Gunjikar, Ajit Gunjikar and 1 more are mutual person
-
Bioxera Pharma Private LimitedSatish Gunjikar, Ajit Gunjikar and 1 more are mutual person
-
Ar-Ex Specialities Private LimitedSatish Gunjikar and Ajit Gunjikar are mutual person
-
Rege Hospital Private Limited
Ajit Gunjikar is a mutual person
Charges (Loans)
₹0
₹3.65 M
Charges Breakdown by Lending Institutions
- The Sarswat Co-Op Bank Ltd; : 0.35 Cr
- The Maharashtra State Financial Corp. : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2003 | The Sarswat Co-Op Bank Ltd; | ₹3.50 M | Satisfied |
| 31 Mar 1975 | The Maharashtra State Financial Corp. | ₹0.15 M | Satisfied |
How Many Employees Work at Ar-Ex Chemicon?
Ar-Ex Chemicon has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ar-Ex Chemicon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ar-Ex Chemicon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
